Mumbai: Drug maker Ranbaxy Laboratories expects to launch a generic version of Astellas Pharma’s Flomax urinary drug in March next year, its chief financial officer said on Thursday.
“Going forward we are going to have lot more. One we have already launched, March there is another,” Omesh Sethi, who is also the president of India’s largest drug maker by sales, told reporters on the sidelines of an industry conference.
“Then there is another big one coming in 2014, Nexium,” he said, referring to AstraZeneca’s anti-ulcer drug.
Last month, Ranbaxy, majority-owned by Japan’s Daiichi Sankyo, said it launched generic version of GlaxoSmithKline’s Valtrex with a 180-day marketing exclusivity in the US.